Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS).
This notice provides public announcement of CDC's intent to fund Approved cooperative agreement applications previously received and competed in response to CDC Funding Opportunity, CDC-RFA-IP11-010, “Enhanced Surveillance for New Vaccine Preventable Disease.” It is the intent of CDC to fund the applications with Patient Protection Affordable Care Act (ACA), Section 4002, appropriations.
CFDA Number 93.533 is the ACA-specific CFDA number for this initiative.
Approximate Current Fiscal Year Funding: $2,750,000.
Approximate Number of Awards: 3-5.
Approximate Average Award: $500,000.
Fiscal Year Funds: Patient Protection and Affordable Health Care Act of 2011.
Anticipated Award Date: 31 May 2011.
Budget Period: 12 months.
Project Period: 5 years.
Application Selection Process: CDC will apply the same selection methodology published in the FOA, CDC-RFA-IP11-010.
The following will be considered in making funding decisions:
- Scientific and technical merit of the proposed project as determined by scientific peer review.
- Availability of funds.
- Relevance of the proposed project to program priorities.
- Funding decision criteria will include a priority score, programmatic importance/value relative to program priorities, past and current surveillance performance and capabilities, research portfolio, geographic locations, and study population consideration (ethnicity, etc.)
- Preference may be given to a medical institution catchment area having a total population of greater than 500,000 persons.
- Applicants must have a letter of support with a research laboratory for rotavirus analyses or they will not be funded.
CDC will add the following Authority to that which is reflected in the published Funding Opportunity:
—Section 4002 of the Patient Protection and Affordable Care Act (Public Law 111-148.)
The effective date for this action is April 19, 2011 and remains in effect until the expiration of the project period of the ACA funded applications..Start Further Info
FOR FURTHER INFORMATION CONTACT:
Elmira Benson, Deputy Director, Centers for Disease Control and Prevention, 2920 Brandywine Road, Atlanta, GA 30341, telephone (770) 488-2802, e-mail Elmira.Benson@cdc.gov.End Further Info End Preamble Start Supplemental Information
On March 23, 2010, the President signed into law the Patient Protection and Affordable Care Act (ACA). ACA is designed to improve and expand the scope of health care coverage for Americans. Cost savings through disease prevention is an important element of this legislation and ACA has established a Prevention and Public Health Fund (PPHF) for this purpose. Specifically, the legislation states in Section 4002 that the PPHF is to “provide for expanded and sustained national investment in prevention and public health programs to improve health and help restrain the rate of growth in private and public sector health care costs. ACA and the Prevention and Public Health Fund make improving public health a priority with investments to improve public health.
The PPHF states that the Secretary shall transfer amounts in the Fund to accounts within the Department of Health and Human Services to increase funding, over the fiscal year 2008 level, for programs authorized by the Public Health Services Act, for prevention, wellness and public health activities including prevention research and health screenings, such as the Community Transformation Grant Program, the Education and Outreach Campaign for Preventative Benefits, and Immunization Programs.
ACA legislation affords an important opportunity to advance public health across the lifespan and to reduce health disparities by supporting an intensive community approach to chronic disease prevention and control.
Therefore, the FOA program activities CDC proposes to fund with ACA appropriations are authorized by the amendment to the Public Health Services Act which authorized the Prevention and Wellness Program.Start Signature
Dated: April 8, 2011.
Business Operation Manager, Centers for Disease Control and Prevention.
[FR Doc. 2011-9417 Filed 4-18-11; 8:45 am]
BILLING CODE 4163-18-P